Trial intelligence / Profile preview

Ketamine for rapid agitation control in the emergency department

NCT03375671Phase 2Completed

Start
May 2018
Primary completion
Mar 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ketamine in psychomotor agitation. Started May 2018; status: completed.

02

Drugs

ketamine
03

Conditions

psychomotor agitation

Beyond the preview

Go deeper on NCT03375671.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03375671.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call